$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
Pembrolizumab efficacy and effects
2026-02-01 22:25:32
Check Details
How much does Pembrolizumab cost?
2026-02-01 22:25:32
Check Details
Is Pembrolizumab a targeted drug or an immune drug?
2026-02-01 22:25:32
Check Details
Manufacturer of Pembrolizumab
2026-02-01 22:25:32
Check Details
Is Pembrolizumab pd1 or pdl1?
2026-02-01 22:25:32
Check Details
Pembrolizumab effects and side effects
2026-02-01 22:25:32
Check Details
Pembrolizumab 2023 drug donation policy
2026-02-01 22:25:32
Check Details
Indications for Pembrolizumab
2026-02-01 22:25:32
Check Details
Is Pembrolizumab a self-pay drug?
2026-02-01 22:25:32
Check Details
Can I buy Keytruda Pembrolizumab for 140,000 and use it for two years?
2026-02-01 22:25:32
Check Details
The difference between imported and domestically produced Pembrolizumab
2026-02-01 22:25:32
Check Details
Pembrolizumab is effective after several courses of treatment
2026-02-01 22:25:32
Check Details
1
2
...
134
135
136
137
138
139
140
...
10220
10221
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Lenvatinib Safety Guide: Baseline Assessment & Adverse Reaction Management
2
Donidalorsen (DAWNZERA®) Side Effects and Safety Management Guide
3
Inluriyo (Imlunestrant): Oral SERD for ER+/HER2- Breast Cancer with ESR1 Mutations
4
Idelalisib: Oral PI3Kδ Inhibitor for Relapsed/Refractory Hematologic Malignancies
5
Lorlatinib (Lorviqua): Oral Targeted Therapy for ALK-Positive Advanced Non-Small Cell Lung Cancer
6
Elafibranor for Primary Biliary Cholangitis: Indication, Dosing, and Safety Overview
7
AbbVie’s TEPKINLY (epcoritamab) Plus R² Granted EU Approval for Relapsed/Refractory Follicular Lymphoma
8
FDA Approves Ibrance for New Maintenance Indication in HR+/HER2+ Breast Cancer
9
FDA Approves Trodelvy for Two First-Line Indications, Redefining Advanced Triple-Negative Breast Cancer Care
10
Cabozantinib: A Pan-Targeted TKI in Modern Oncology Practice
11
Managing Amivantamab Infusion Reactions: A Clinical Guide for International Practice
12
Global Oncology Update: Breakthroughs in Advanced Cancer Survival and Novel Therapies